APUS — Apimeds Pharmaceuticals US, Inc.

Stock analysis, AI verdict, fundamentals & technical signals

Rating: NEUTRAL

Price: $3.01

About Apimeds Pharmaceuticals US, Inc.

Apimeds Pharmaceuticals US, Inc. is a clinical stage biopharmaceutical company in the United States. The company is headquartered in Hopewell, New Jersey.

See the full interactive analysis & chart →

Informational only — not investment advice.